P070 - Cabazitaxel as 3rd-4th line of treatment in castration-resistant metastatic prostate cancer - assessment of the impact of prior treatments on survival outcomes
| Autor: | Valente, A.D.C., J. Costa, M., Nogueira Costa, I., Reis, J., Baptista Freitas, M., Lopes De Almeida, C., Ribeiro, M.J., Meireles, S., Augusto, I. |
|---|---|
| Zdroj: | In European Urology Open Science November 2021 33 Supplement 3:S294-S294 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|